(A) Images acquired at indicated time interval in the presence of 1μM TTX, either without nicotine bath perfusion (1st row) or with 10 μM nicotine (the rest of the rows). The nicotine-induced VSDI signals were not blocked by pre-perfusion of the α7 nAChR antagonist MLA (10 nM, 3rd row), but by the non-α7 nAChR antagonist DHßE (1μM, 4th row). Further 4mM KCl application induced depolarization in slices when nicotine effects were blocked by DHßE (4th row), confirming the viability of the slices. The last row shows a slice stained with FM 1–43 (a non-voltage-sensitive dye), which failed to induce detectable fluorescence changes after nicotine application. The figure legend (top right) indicates values of fluorescence change corresponding to color of pixels. Any pixel with a fluorescence change below 0.25% was left transparent so that a gray-scale background image of the slice could be shown to indicate the location of voltage changes. (B) Activation map of nicotine effect in TTX treated slices show sequence of nicotine-induced depolarization (images derived from the same slice as the 3rd row in A. Colored pixels indicate areas depolarized at 2 (green), 3 (brown) and 4 (red) min after bath-application of nicotine (10 μM). The map was derived after smoothing with a 9×9 spatial filter. The nicotine-induced depolarization started in ECVI and part of SbSO at 2 min, and then extended to neighboring regions at 3 and 4 min. Colored areas are regions above a threshold of 0.25% fluorescent change. (C) Averages of fluorescent changes in ECVI induced by bath-application of nicotine (10 μM) in the presence of TTX (1 μM, red line, n = 8), TTX and MLA (10 nM, blue line, n = 5), or TTX and DHßE (1 μM, green line, n = 6). Error bars: s.e.m.. Abbreviations: PRh, pararhinal cortex; Sb, subiculum; so, stratum oriens; sr, stratum radiatum; slm, striatum lacunosum moleculare; Den, dentate; PaSb, parasubiculum; PrSb, presubiculum.